ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Actonel 35 mg, magensaftresistente Tabletten - 12
69144002 Future Health Pharma GmbH
Actonel 35 mg, magensaftresistente Tabletten14.02.2024
  14.02.2024
Risedronic Acid (M05BA07) 
WHO-DDD13.02.2029
12
07.99. 
B  
No 
IP 
PR  
k.A.PR
  
7680691440021Synthetika
  
Composition
natrii risedronas 35.0 mg corresp. risedronas 32.48 mg, cellulosum microcristallinum silicificatum, dinatrii edetas, carboxymethylamylum natricum A, acidum stearicum, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum, triethylis citras, talcum, E 172 (flavum), simeticonum, polysorbatum 80, pro compresso obducto corresp. natrium 16.64 mg.
Packungsbestandteile
Gastric juice resistant tablets
 
Active AgentDose
Sodium Risedronate35 mg correspond Risedronas 32.48 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
Acidi Methacrylici Überzug
Acidum Stearicum  
Carboxymethylamylum Natricum A  
Cellulosum Microcristallinum Silicificatum  
Dinatrii Edetas  
E 172 color.
Ethylis Acrylatis Polymerisatum Dispersio30  
Magnesii Stearas  
Per Centum  
Polysorbatum 80  
Pro Compresso Obducto  
Simeticone  
Talcum  
Triethylis Citras  
Source
Data was imported : 07.03.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home